Therapy Areas: Diabetes
12 June 2019 - - German pharmaceutical company Boehringer Ingelheim and US-based Eli Lilly and Company (NYSE: LLY) have released full data from the CAROLINA trial demonstrating that Trajenta ...
11 June 2019 - - US-based biopharma company Dance Biopharm Holdings, Inc has presented Phase 2 Samba 04 clinical trial results for its inhaled preservative-free human insulin, Dance 501, for the treat...
11 June 2019 - - A pre-specified exploratory analysis of renal data from the Phase III DECLARE-TIMI 58 trial, the broadest cardiovascular outcomes trial of a sodium-glucose co-transporter 2 (SGLT...
11 June 2019 - - The European Medicines Agency granted orphan designation to US-based ophthalmology company Acucela Inc's leading drug candidate emixustat hydrochloride for the treatment of Starg...
11 June 2019 - - US-based molecular biotechnology company ProtoKinetix, Inc. (OTCQB: PKTX) has reached midpoint of a Phase-1 first-in-human clinical trial of AAGP PKX-001 treated islet cells used...
11 June 2019 - US-based ProtoKinetix has reached the midpoint of a Phase-one first-in-human clinical trial of AAGP PKX-001 treated islet cells used in conjunction with the Edmonton Protocol for the tr...